ClinicalTrials.Veeva

Menu

This is a Retrospective Observational Study Looking at the Characteristics and Outcomes of Participants Taking Inflectra Using the CorEvitas Rheumatoid Arthritis Registry

Pfizer logo

Pfizer

Status

Completed

Conditions

Arthritis, Rheumatoid

Treatments

Drug: Inflectra

Study type

Observational

Funder types

Industry

Identifiers

NCT05375942
C1231007

Details and patient eligibility

About

This is a retrospective observational study looking at the characteristics and outcomes of participants taking Inflectra using the CorEvitas Rheumatoid Arthritis Registry.

Enrollment

255 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Be at least 18 years of age
  • Have been diagnosed with RA by a rheumatologist
  • Have initiated treatment with Inflectra
  • Had assessment of effectiveness in patients who have at least one follow up visit.

Exclusion criteria

  • No additional exclusion criteria

Trial design

255 participants in 2 patient groups

characteristics of patients newly initiated on Inflectra
Treatment:
Drug: Inflectra
Drug: Inflectra
outcomes after initiating Inflectra
Treatment:
Drug: Inflectra
Drug: Inflectra

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems